3D Bio

3D Bio

Leadership
Dan Cohen (CEO/Co-founder), Tanny Bachrach (CSO)
Website
3dbiocorp.com
Twitter
@3dbiocorp
Location
New York, NY
RELATIONSHIP
Expa Ventures

Implanting 3D printed living tissues in patients.

3DBio is a clinical-stage biotechnology company and leader in regenerative medicine using novel 3D-bioprinting and materials technologies to deliver safe, functional and personalized living tissues and organs, engineered on-demand for patients.  3DBio’s pioneering approach develops living tissue implants with structural and functional integrity with a four-part technology platform, including: novel and proprietary 3D-bioprinter (GMPrint™), bio-ink (ColVivo™), specialized cell culture system, and implantable protective shell (Overshell Technology). Today, 3DBio is breaking new ground with a clinical trial underway to treat Microtia, three additional programs nearing the clinic, and multiple life-changing treatment approaches in development. 3DBio is committed to providing healthcare professionals with safe and functional implant solutions delivering optimal patient outcomes.


BY BUILDERS
FOR BUILDERS
BY BUILDERS
FOR BUILDERS
BY BUILDERS
FOR BUILDERS
BY BUILDERS
FOR BUILDERS
BY BUILDERS
FOR BUILDERS
BY BUILDERS
FOR BUILDERS
BY BUILDERS
FOR BUILDERS
No interactions or Javascript Involved